![Targeting a $300M market, Almirall starts selling 'less greasy' psoriasis cream in the EU | Fierce Pharma Targeting a $300M market, Almirall starts selling 'less greasy' psoriasis cream in the EU | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1645529501/Almirall-fachada-centro-I%20D_3.jpg/Almirall-fachada-centro-I%20D_3.jpg?VersionId=kqosE_6TfKuovt6JJaqg5wGwZ9svK4M7)
Targeting a $300M market, Almirall starts selling 'less greasy' psoriasis cream in the EU | Fierce Pharma
![Lilly/Almirall drug maintains clearer skin in eczema patients; Lilly plans FDA filing | Seeking Alpha Lilly/Almirall drug maintains clearer skin in eczema patients; Lilly plans FDA filing | Seeking Alpha](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/521503314/image_521503314.jpg?io=getty-c-crop-4-3)
Lilly/Almirall drug maintains clearer skin in eczema patients; Lilly plans FDA filing | Seeking Alpha
![Almirall Exercises its Option with Dermira to License Rights to Lebrikizumab in Europe for Atopic Dermatitis | Business Wire Almirall Exercises its Option with Dermira to License Rights to Lebrikizumab in Europe for Atopic Dermatitis | Business Wire](https://mms.businesswire.com/media/20190624005834/en/729627/5/3912963_Almirall_logo.jpg)
Almirall Exercises its Option with Dermira to License Rights to Lebrikizumab in Europe for Atopic Dermatitis | Business Wire
![File:184 Casa Ferrer i Vidal, o Cal Genís, rbla. Principal 61 - c. Almirall Colom (Vilanova i la Geltrú).jpg - Wikimedia Commons File:184 Casa Ferrer i Vidal, o Cal Genís, rbla. Principal 61 - c. Almirall Colom (Vilanova i la Geltrú).jpg - Wikimedia Commons](https://upload.wikimedia.org/wikipedia/commons/6/6c/184_Casa_Ferrer_i_Vidal%2C_o_Cal_Gen%C3%ADs%2C_rbla._Principal_61_-_c._Almirall_Colom_%28Vilanova_i_la_Geltr%C3%BA%29.jpg)